Advisor Group Holdings, Inc. Actinium Pharmaceuticals, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 6,034 shares of ATNM stock, worth $6,818. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,034
Previous 10,289
41.35%
Holding current value
$6,818
Previous $19,000
63.16%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$1.83 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$777,2730.0% of portfolio
-
State Street Corp Boston, MA621KShares$701,8140.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$564,1630.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $28.5M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...